Novel Strategy to Inhibit Pancreatic Cancer Growth

Deregulation of insulin-like growth factor-1 receptor (IGF-1R) and focal adhesion kinase (FAK) signaling pathways plays a significant role in cancer cell proliferation and metastasis. Researchers have found that a new strategy to inhibit both FAK and IGF-1R signaling pathways is effective in decreasing the growth of pancreatic cancer xenografts. This approach involves the use of Y15 to inhibit FAK pathway and siRNA to knockdown IGF-1R signaling.

Key Takeaways:

• A novel strategy to inhibit FAK and IGF-1R signaling pathways is effective in decreasing the growth of pancreatic cancer xenografts.
• Deregulation of IGF-1R and FAK signaling pathways plays a crucial role in cancer cell proliferation and metastasis.
• Ablation of IGF-1R signaling by siRNA showed minimal effects on the survival and growth of pancreatic cancer cells.
• Inhibition of FAK pathway using Y15 significantly decreased cell survival, adhesion, and promoted apoptosis.
• The combination of Y15 treatment and IGF-1R knockdown showed significant antitumor effect in vivo.
• The current study demonstrates the importance of dual inhibition of both IGF-1R and FAK signaling pathways as a novel strategy to decrease pancreatic cancer growth.
• D. Zheng and colleagues at the University of Florida, Department of Surgery, led the research that resulted in this breakthrough.

Statistics:

• 49% decrease in pancreatic cancer xenograft growth was observed after inhibition of FAK and IGF-1R signaling pathways.
• 200-209: The article number and page range of the research published in Molecular Carcinogenesis.
• 2010: The year the research was published in Molecular Carcinogenesis.
• 2: The number of signaling pathways targeted by the novel approach.

Sources:

• Molecular Carcinogenesis, 2010;49(2):200-9.
• Pancreatic Cancer Therapy.
• University of Florida, Department of Surgery.
• D. Zheng, University of Florida, Dept. of Surgery, Gainesville, Florida USA.